Clin Exp All 2002; 32:301±308
DNA microarrays to study gene expression in allergic airways
M. Benson, P. A. Svensson*, B. Carlsson*, M. JernaÊs*, J. Reinholdt{, L. O. Cardell and L. Carlsson*
Allergy Laboratory, Department of Oto-Rhino-Laryngology, MalmoÈ University Hospital, MalmoÈ, *Research Centre for Endocrinology and Metabolism,
Sahlgrenska University Hospital, Gothenburg, Sweden, and {Department of Medical Microbiology and Clinical Immunology, Aarhus University Hospital,
Aarhus, Denmark
Summary
Background Allergic rhinitis results from interactions between a large number of cells and mediators in different compartments of the body. DNA microarrays allow simultaneous measurement of
expression of thousands of genes in the same tissue sample.
Objective To study gene expression in nasal mucosal biopsies from patients with allergic rhinitis
using DNA micro-arrays.
Methods Nasal biopsies were obtained from 14 patients with symptomatic birch pollen-induced
allergic rhinitis and ®ve healthy controls. RNA was extracted from the biopsies and pooled into one
patient pool and one control pool. These were analysed in duplicate with DNA micro-arrays
containing more than 12000 known genes.
Results Approximately half of the genes were expressed in the patient and control samples. Guided
by the current literature we chose 32 genes of possible relevance to allergic airway in¯ammation and
investigated their relative expression. Among these, transcripts encoding immunoglobulins and their
receptors were most abundant. The expression of cytokines and growth factors was low, whereas
their corresponding receptors and cell surface markers displayed higher expression levels. IgA had
the highest expression of all 12626 genes. RT-PCR showed that IgA1 was the predominant subclass.
This was con®rmed by the protein level in nasal ¯uids. Allergen-speci®c IgA was signi®cantly higher
in patients than in controls and correlated signi®cantly with eosinophil granulae proteins.
Conclusion DNA micro-array analysis can be used to identify genes of possible relevance to allergic
airway in¯ammation. In this study, the expression pro®le in the nasal mucosa was quantitatively
dominated by immunoglobulins, particularly IgA. Protein analyses in nasal ¯uids indicated a role for
allergen-speci®c IgA in eosinophil degranulation.
Keywords allergic rhinitis, DNA microarrays, gene expression
Submitted 10 April 2001; revised 30 July 2001; accepted 20 August 2001
Introduction
In recent years detailed understanding of mucosal responses in
allergic rhinitis has been gained [1,2]. Cytokines from type 2 Th2
cells induce IgE-synthesis, as well as degranulation of eosinophils and mast cells. However, an increasing number of other
cells and their products could be implicated in the pathogenesis
of allergic rhinitis, e.g. other cytokines and immunoglobulins
may contribute to degranulation of eosinophils, and growth
factors protect the mucosa by maintaining epithelial integrity
[3,4].
While most of the mediators have been described in the
mucosa it is not clear to what extent they are produced locally,
e.g. mucosal immunoglobulins may be synthesized locally but
also be serum-derived [5±8]. Moreover, many mediators are
synthesized when in¯ammatory cells differentiate in the bone
marrow. It is also of note that in¯ammatory cells are not equally
distributed between the nasal mucosa and lumen. Lymphocytes
Correspondence: Mikael Benson, Allergy Laboratory, Department of OtoRhino-Laryngology, MalmoÈ University Hospital, S-205 02 MalmoÈ, Sweden.
# 2002 Blackwell Science Ltd
predominate in the mucosa and eosinophils in the lumen [9].
Thus, the two compartments may have distinct immunological
characteristics. Examination of gene expression in the nasal
mucosa could contribute to understanding of the role of this
compartment.
DNA micro-arrays consist of a matrix with attached DNA
sequences that allow simultaneous analysis of expression of
thousands of genes [10]. With the help of DNA microarrays
great diversity of gene expression has been shown in activated T
cells [11]. There are few DNA micro-array studies of human
tissues. Using surgical material transcriptional responses in
rheumatoid arthritis and colon cancer have been examined
[12,13]. This could result in identi®cation of novel diseaserelated genes. The most common approach is to look for
genes with a twofold or higher difference in expression levels
between two groups [14]. However, smaller differences can have
pathogenetic relevance. Conversely, higher differences can be
due to methodological or non-disease-related biological variation. Bioinformatic methods to interpret data from DNA
microarray analyses are continuously developed, and have
been described in large studies of malignant diseases [15,16].
As of yet, there are no published DNA microarray studies of
301
302 M. Benson et al.
tissues from patients with allergic diseases. Such studies are
complicated by the dif®culties in obtaining suf®cient material.
However, the recent development of protocols that use only a
few micrograms of total RNA instead of mRNA may allow
DNA microarray analysis of small biopsies obtained in clinical
settings [17,18].
The aims of this study were to: (i) determine if DNA microarrays can be used to study gene expression in biopsies of nasal
mucosa from patients with allergic rhinitis and healthy controls;
(ii) obtain an estimate of the relative transcriptional levels of
cytokines, growth factors, their receptors, cell surface markers,
eosinophil and neutrophil granulae proteins, immunoglobulins
and their receptors in the nasal mucosa from patients with
allergic rhinitis and healthy controls; and (iii) compare transcriptional responses in the mucosa with proteins in nasal ¯uids.
Materials and methods
The study included 14 patients with symptomatic birch polleninduced allergic rhinitis and ®ve healthy controls. Both patients
and controls were seen during the birch pollen season. The
median (range) age of the patients and the controls were 40
(18±53) years and 35 (29±50) years, respectively. Eight patients
and four controls were women. The diagnosis of birch polleninduced allergic rhinitis was based on a positive history of
seasonal allergic rhinitis and positive skin prick tests against
birch pollen. All patients were symptomatic at the time of inclusion in the study. The controls were all symptom-free, had no
history of allergic rhinitis or any other atopic disease, and had
negative skin prick tests against a panel of allergens, including
birch, timothy, mugwort, house dust mite (Dermatophagoides
pteronyssimus and D. farinae), horse, dog, cat and moulds
(Cladosporium and Alternaria). The study was approved by the
Ethics Committee of the Medical Faculty, Lund University.
Biopsies were obtained as described from the nasal inferior
turbinate, frozen immediately in liquid nitrogen, and then
stored at 70 C [19].
Nasal lavage ¯uids were obtained as previously described
[20]; after clearing excess mucous by forceful exsuf¯ation, sterile
normal saline solution of normal room temperature was aeorosolized into each nostril, while alternatingly clearing the other.
The nasal ¯uids were allowed to return passively and collected
in a graded test tube until 4mL were recovered. The total
number of cells/mL was computed in a BuÈrker chamber. The
¯uids were then centrifuged for 10min at 1334g at 4 C. The
supernatant was separated from the pellet. The pellet was used
to prepare slides that were stained according to the MayGruÈnwald and Giemsa method for morphological assessment
of cells in the ¯uid by two independent microscopists. The
percentages of epithelial cells, eosinophils, neutrophils and
mononuclear cells out of a total of 100 cells/slide were computed, and then the total number of each cell type/mL.
Preparation of cRNA
RNA was isolated using the RNeasy kit (Quiagen, Valencia,
CA, USA). RNA concentrations were determined spectrophotometrically. The sample-by-sample weights of RNA in the
patients and controls were 2.9, 3.2, 0.9, 1.3, 1.9, 1.2, 0.9, 2.3,
0.8, 1.4, 1.5, 1.0, 0.75, 0.9mg and 1.5, 3.1, 2.7, 3.1, 4.6mg,
respectively. The RNA was pooled into one patient pool and
one control pool and used for target preparation. Each pool was
divided and analysed in duplicates according to the following
procedure. Double-stranded cDNA was prepared using Life
Technologies Superscript Choice system (Life Technologies,
Paisley, UK) and an oligo(dT)24-anchored T7 primer. Biotinlabelled cRNA was synthesized from the total amount of cDNA
by in vitro transcription with biotin-labelled nucleotides and T7
RNA-polymerase, Enzo BioArray High Yield RNA Transcript
Labelling Kit, according to the manufacturers instructions
(Enzo Diagnostics, Farmingdale, NY, USA). One round of
ampli®cation was performed. Labelled cRNA was puri®ed
using RNeasy columns (Qiagen) and 20mg of biotinylated
cRNA was fragmented at 94 C for 35min with 1fragmentation buffer (40mm Tris-acetate pH8.1, 100mm KOAc, 30mm
MgOAc) in a ®nal volume of 40mL. Gel electrophoresis was
performed to verify expected size distribution of cDNA, cRNA
and fragmented cRNA. Hybridization cocktails were prepared
by mixing 15mg fragmented cRNA (adjusted for RNA originating from the starting material), 50pmol/L B2 control oligonucleotide (Genset, Paris, France), 1.5, 5, 25 and 100pmol/L,
respectively, of BioB, BioC, BioD and Cre control transcripts
generated by in vitro transcription using the plasmids pGIKSBioB, pGIKS-BioC, pGIKS-BioD and pGIKS-Cre as template
(ATCC, Manassas, VA, USA), 0.1mg/mL herring sperm, 0.5
mg/mL acetylated BSA, and 1MES hybridization buffer (100
mmol/L MES, 1m NaCl, 20mmol/L EDTA, 0.01% Tween 20)
in a ®nal volume of 300mL.
Oligonucleotide array hybridization and scanning
The hybridization cocktails were denaturated at 99 C for 5min,
transferred to 45 C, incubated for 5min and then centrifuged
for 5min to pellet debris. One HuGeU95A array was hybridized
for each duplicate sample (Affymetrix, Santa Clara, CA, USA).
Pre-hybridization solution was exchanged with hybridization
cocktail and hybridization was carried out for 16h at 45 C.
Washing and staining was carried out using a ¯uidics station
and a confocal scanner essentially according to the manufacturers instructions (Affymetrix). In brief, the hybridized probe
array was washed and stained with streptavidin phycoerythrin
conjugate and scanned by the Hewlett-Packard (HP)
GeneArrayTM Scanner at the excitation wavelength of 488nm.
The amount of light emitted at 570nm is proportional to bound
target at each location on the probe array. A signal-ampli®cation step was performed using biotinylated antistreptavidin
antibody and the array was scanned again.
Analysis of DNA microarray data
Scanned output ®les were visually inspected for hybridization
artifacts and then analysed with GENECHIP 3.1 software (Affymetrix). To allow comparison of gene expression between patients and controls the arrays were scaled to an average intensity
of 500 [10,11]. RNA expression was quantitatively estimated by
computing the average difference between a set of oligonucleotides that perfectly matched the gene and a set of mismatch
control oligonucleotides (Fig. 1). The average difference value
will subsequently be referred to as the gene expression level and
given in arbitrary units. In addition, a qualitative estimate of
gene expression was given by `the absolute call'. This was
obtained by an algorithm based on the signal intensity and
quality of the average difference (Affymetrix). With the absolute
call gene expression is classi®ed as absent, marginal or present.
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
DNA microarrays
303
PM
MM
Fig. 1. Magni®cation of a DNA microarray
after hybridization with RNA. Each cell
represents an oligonucleotide. These are
arranged in pairs consisting of one perfect
match (PM) and one control mismatch (MM)
oligonucleotide. A gene transcript is usually
represented by 16±20 different probe cells. One
such transcript is marked with a grid. The size of
a probe cell is 24mm and each cell contains
millions of oligonucleotides. The colour
intensities of the probe cells are proportional to
their hybridization intensities (HuGeneFL DNA
microarray, derived from a pilot study).
Analysis of hybridization, cDNA synthesis and in vitro
transcription quality of the DNA microarrays
To examine variability in hybridization quality in the DNA
micro-arrays, four control bacterial and phage gene cRNAs,
BioB, BioC, BioD and Cre, were analysed on each DNA microarray. BioB, BioC, BioD and Cre were all present according to
the absolute call criterion. In vitro transcription and cDNA
synthesis quality were assessed by comparing 30 and 50 expression levels of actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in the four DNA microarrays. Actin and
GAPDH expression levels were checked and differed less than
30% between 30 and 50 regions of the transcripts.
Data mining strategy
Guided by current literature, transcripts of possible relevance
to mucosal in¯ammatory responses were analysed: cytokines
(IL-2, IL-4, IFN-g, TNF-a) [1,2,7,20±24], their receptors (IL-2
receptor(R)g, IFN-Ra, IL-4Ra, TNF-R1) [2,25], growth
factors (heparin-binding epidermal growth factor (HB-EGF),
transforming growth factor (TGF)-a, amphiregulin, epiregulin,
betacellulin), their receptors, all of which belong to the c-erbB
family of receptors (epidermal growth factor (EGF)-R,
c-erbB2, c-erbB3) [3], cell surface markers (CD3, CD4, CD45,
CD8, CD68, HLA-DRb), eosinophil and neutrophil granulae
proteins (eosinophil cationic protein (ECP), eosinophil-derived
neurotoxin (EDN), myeloperoxidase (MPO) [26]), immunoglobulins (IgA, IgD, IgE, IgG) and their receptors (polymeric
Ig-R, IgE-R, IgG-R) [4±6,8]. The identities of the analysed
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
transcripts were veri®ed by BLAST analysis (http://www.ncbi.
nlm.nih.gov/BLAST/) and by database searches in ExPASy
Molecular Biology Server (http://www.expasy.ch). With the
blast analysis, the DNA sequences from the GeneChip were
compared with all other sequences that are available on the
world-wide web. The Molecular Biology server gives descriptions of the trancripts both on the molecular and protein
level.
Analysis of IgA subclasses by RT-PCR
For ®rst strand cDNA synthesis 0.5mg RNA was heat denatured and reverse transcribed using 0.5mg random hexamers
(Roche Diagnostics, Mannheim, Germany) and 20U AMVreverse transcriptase (Promega, Madison, WI, USA) in
AMV-reverse transcriptase buffer (Promega). PCR was done
in Taq buffer (Roche Diagnostics), 1mm of primers IgA-808 (50 CTCAGGTGGTCCTTGAAC-30 ; Genset, Paris, France) and
IgA-217 (50 -AGTGTGACCTGGAGCGAA-3; Genset), 50ng
cDNA, dNTP (0.2mm each), using GeneAmp PCR system
9600 (Perkin-Elmer, Foster City, CA, USA). The thermocycler
was programmed for an initial denaturation at 94 C (1min),
followed by 30 cycles with 30s denaturation at 94 C, 30s
annealing at 60 C and 60s elongation at 72 C. The expected
size of the IgA1 and IgA2 PCR fragments was 380bp. PCR
products, Eco RI-digested PCR products, Hinf I-digested PCR
and a 1Kb DNA-ladder (Life Technologies, Gaithersburg,
MD, USA) were separated on a 2% agarose gel containing
ethidium bromide.
304 M. Benson et al.
Nasal ¯uid mediator assays
IgE, granulae proteins and albumin These assays were
obtained from Pharmacia & Upjohn Diagnostics AB
(Uppsala, Sweden). Total IgE was determined with a competitive radioimmunoassay. IgE concentrations are given in kU/L
(1kU2.42mg).Bet v 1- and bet v 2-speci®c IgE as well as ECP
levels were determined with ¯uoroenzyme immunoassays.
EDN, MPO and albumin were determined using competitive
radioimmunoassays.
IgA Levels of total IgA, IgA1 and IgA2 were estimated by
titration in calibrated enzyme-linked immunosorbent assays
(ELISA), essentially as previously described [27].
In an assay for quanti®cation of nasal IgA antibodies to birch
allergen, wells intended to receive serial dilutions of test samples
were coated with recombinant bet v 1, kindly donated by ALKÂ , Hùrsholm, Denmark. The assay was calibrated by
ABELLO
titration of puri®ed S-IgA2 standard in other wells of the plate
coated with IgA2 subclass-speci®c monoclonal antibody
(Nordic, Tilburg, the Netherlands). After incubation with
samples and standard, the plate was developed with a-chainspeci®c, peroxidase-conjugated rabbit antibodies. The adopted
method of calibration, involving the binding of S-IgA2 standard to a subclass-speci®c monoclonal antibody of relatively low
af®nity (Ka 3.7H107) [28], proved advantageous by generating
a standard titration curve parallel to that for bet v 1-reactive
IgA antibodies in most test samples. Besides, antibodies could
be estimated in gravimetric units (mg/L)
Statistics
The levels of nasal ¯uid eosinophils, neutrophils, ECP, EDN,
Total IgA, IgA1, IgA2 and albumin were compared using the
non-parametric Mann±Whitney U-test. The Spearman rank
correlation test was used to determine if IgA1, IgA2 and bet
v 1-speci®c IgA were correlated with ECP and EDN. P-values
<0.05 were considered signi®cant. As the nasal biopsies were
pooled into one patient pool and one control pool, differences
in gene expression were not tested statistically.
Results
Analysis of gene expression in nasal biopsies from patients
and controls
The total numbers of genes that were present according to the
absolute call criterion in the duplicate DNA microarray analysis of the patient sample were 5773 and 6477, respectively. The
corresponding numbers in the controls were 5944 and 6544.
Ninety per cent of the transcripts had identical absolute calls
in the duplicate chips of both controls and patients. The expression level of each gene transcript was estimated by computing
the average difference in hybridization intensity between a set of
perfect and mismatch oligonucleotides (Fig. 1). The expression
levels of the transcripts ranged from 20 to 117813 arbitrary
units. The majority of these, approximately 90%, had expression levels lower than 1000. Genes associated with expression
levels greater than 1000 included known high abundance genes,
such as tubulin and ubiquitin. By contrast, mRNA for albumin,
which is not expected to be expressed in the nasal mucosa, was
absent in both patient and control DNA microarrays. Four
hundred and eighty-six genes had expression levels that were
more than twofold higher in the patients than in the controls,
and 416 genes had more than twofold lower expression levels in
the patients.
Analysis expression of genes related to mucosal responses in
nasal biopsies from patients and controls
Guided by current literature, 32 transcripts of possible relevance to mucosal in¯ammatory responses were analysed: cytokines, growth factors, their receptors, cell surface markers,
eosinophil and neutrophil granulae proteins, immunoglobulins
and their receptors [1±8,20±26]. A graphic overview of the
expression levels of the transcripts in patients and controls is
given in Fig. 2. The levels varied from 20 to 117813 arbitrary
units. IgA had the highest expression level in patients and
controls, 117813 and 114000, respectively. IgD, IgG and IgM,
the polymeric immunoglobulin receptor and the IgG receptor
also had high expression levels. The expression levels of IgE
were <100 in both patients and controls, i.e. more than 1000
times lower than IgA. Both IgE and its receptor were absent
according to the absolute call criterion. Most cytokines and
growth factors, except TNF-a, were also absent. By contrast,
their receptors were generally present, as were CD markers.
Transcripts for neutrophil and eosinophil granulae proteins
were absent in both patients and controls. The differences in
gene expression between patients and controls were generally
modest.
Nasal ¯uid protein levels and cell counts
In order to compare immunological responses in the nasal
mucosa and lumen, nasal ¯uid proteins and cells were analysed.
The differences in mucosal gene expression of IgA and IgE were
similar to the corresponding proteins in nasal ¯uids; IgA was
found in mg/L and IgE in mg/L. Total IgE was higher in patients
than in controls (P<0.01), but bet v 1- and bet v 2-speci®c IgE
were not detectable in either patients or controls (Table 1). The
median eosinophil counts in the patients were 1.65104/mL
(0.1±8.3) and 0.0/mL (0.0±0.0) in the controls (P<0.001). The
corresponding ®gures for neutrophils were 6.8104/mL
(0.1±21.3) vs. 0.08104/mL (0±20.0) in the controls (P<0.05).
In contrast to gene expression in the nasal mucosa, albumin was
found in high concentrations (mg/L) in nasal ¯uids, and was
signi®cantly higher in patients than controls (P<0.01). ECP,
EDN and MPO were found in mg/L. ECP and EDN, but not
MPO, were signi®cantly higher in the patients (both P<0.01,
Table 1).
IgA and its relation to eosinophil degranulation.
Because of the high expression of IgA in both nasal mucosa and
¯uids and its possible role in eosinophil degranulation, IgA [4]
was further analysed. To obtain an estimate of the expression
level of IgA relative to the other mucosal genes, IgA was compared with all 12626 genes on the DNA micro-array genechip;
IgA was the transcript with the highest expression level. RTPCR analysis was performed to distinguish between IgA1 and
IgA2 in the patients. This analysis showed that IgA1 was the
predominant isoform (Fig. 3). In nasal ¯uids IgA1 levels were
signi®cantly higher than IgA2 (P<0.001), but there were no
differences between patients and controls. The concentrations
of bet v 1-speci®c IgA were signi®cantly higher in patients than
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
305
DNA microarrays
IgA
100 000
IgM
IgD
pIg-R
Patients
10 000
Fig. 2. Scattergram showing gene
expression levels in patients and controls
(®lled squares). The open square indicates
transcripts that were absent according to the
absolute call criterion. The diagonal line is the
line of identity. Abbreviations:
ECPeosinophil cationic protein,
EDNeosinophil-derived neurotoxin,
EGF-Repidermal growth factor receptor,
HB-EGFheparing-binding epidermal
growth factor, IFNinterferon,
ILinterleukin, IL-2RgIL-2 receptor g,
IFN-gRinterferon-g receptor,
MPOmyeloperoxidase, pIg-Rpolymeric
immunoglobulin receptor,
TGFtransforming growth factor,
TNF-Rtumour necrosis factor receptor.
HLA-DR
IgG-R
TNF-R
C-erbB3
IL-2Rγ
IFN-γR
c-erbB2
IL-4R
TNF-α
CD45
CD8
CD3
1000
CD4
EGF-R
100
MPO, ECP, EDN, IgE, IgE-R, CD68
IFN-γ, IL-2, IL-4,TGF, HB-EGF, amphiregulin, epiregulin, betacellulin
100
1000
10 000
100 000
Controls
Table 1. Nasal ¯uid levels of MPO, ECP, EDN, IgE and IgA in patients and
controls
ECP (mg/L)
EDN (mg/L)
MPO (mg/L)
IgE (kU/L)
Total IgA (mg/L)
IgA1(mg/L)
IgA2(mg/L)
Betv 1 IgA(mg/L)
Albumin (mg/L)
IgG
Controls
Patients
5.0 (0±8)
12.8 (0±24)
66.2 (13±655)
2.5 (2.3±2.8)
31.7 (24.1±137)
23.5 (19.8±111)
5.5 (3.5±23.6)
0.0 (0.0±0.0)
9.6 (5.2±114)
31.7 (3±83)**
158.0 (10±634)**
167.5 (11±1000)
2.8 (2.4±5.2)**
79.6 (25.3±114)
59.6 (23.1±116)
8.4 (2.4±20.0)
3.0 (0.0±32.6)**
109.7 (10±393)**
Median (range) values are given. **P<0.01 compared with controls,
Mann±Whitney U-test.
in controls (P<0,01). To examine if IgA might contribute to
eosinophil degranulation, correlation analyses between IgA1,
IgA2, bet v 1-speci®c IgA and ECP, EDN were performed.
IgA1, but not IgA2 was signi®cantly correlated to ECP
(r0.64, P<0.01) and to EDN (r0.55, P<0.05). Signi®cant
correlations between bet v 1-speci®c IgA and ECP (r0.61,
P<0.01) and EDN (r0.55, P<0.05) were also found.
Discussion
Allergic rhinitis results from interactions between a large
number of cells and mediators. These are synthesized in different compartments of the body, e.g. the bone marrow, lymph
nodes and the nasal mucosa. These compartments could, by
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
inference, have different pathogenetic roles. The aim of this
study was to examine gene expression in the nasal mucosa
using DNA microarrays. This technique allows analysis of
thousands of genes in the same sample. DNA micro-array
analyses have been used to study gene expression in tissues
from patients with rheumatoid arthritis and cancer [12,13],
but not in allergic diseases. The studies of arthritis and cancer
were performed on surgically removed specimens. Recent methodological improvements permit DNA microarray analysis of
small biopsies obtained in clinical settings [17,18]. This led us to
examine whether gene expression could be determined in biopsies of nasal mucosa from patients with allergic rhinitis and
healthy controls. However, with current protocols the amounts
of RNA obtained from our biopsies did not allow individual
samples to be analysed. Therefore this study was performed in
pooled RNA samples. It is possible that methodological alterations, e.g. adding a second round of in vitro transcription,
would have increased the amount of RNA. Such alterations
have to be balanced against every procedure in the DNA microarray technology being a potential source of ¯uctuation.
Further research is likely to provide improved protocols for
cRNA synthesis and DNA micro-arrays with higher sensitivity
[29,30].
Pooling of the samples might lead to the signals being confounded by mixed cell populations and individuals. However,
the range and distribution of expression level values were similar to those found in DNA microarray studies of single cell
lines [11,31]. Known high-abundance genes, such as b-tubulin
and ubiquitin, had high expression levels in patients and controls, whereas cytokines had low values. The overall performance of the DNA microarrays was assessed by different control
experiments: the hybridization quality was supported by the
306 M. Benson et al.
M
ND
Eco RI
Hinf I
516 bp ⇒
220 bp ⇒
four control bacterial and phage gene cRNAs being present on
all DNA microarrays; the quality of in vitro transcription and
cDNA synthesis was indicated by the 5' expression levels of
actin and GAPDH being more than 70% of the 30 intensities.
Although DNA microarrays have been validated with other
methods [11,31±33] it should be emphasized that transcriptional
responses may not be representative of protein expression patterns. Moreover, very large datasets are generated. In this study
approximately half of more than 12000 analysed genes were
expressed. These could include genes of both known and unknown relevance, and potentially new information about
pathogenetic mechanisms. Identi®cation of such genes may be
the most complicated part of DNA microarrays.
Three basic analytical steps have been described [10].
(i) Normalization or scaling of the data so that paired samples
can be compared [11]. (ii) Identi®cation of disease-related transcripts. The most common approach is to search for genes with
twofold or higher differences in expression between two groups
[14]. However, this is likely to result in many false negative and
positive identi®cations. Pathogenetic genes can have lower differences in expression levels. Conversely, higher differences can
be due to non-disease-related biological or methodological variation [14,34]. Thus, a search for pathogenetic genes among the
902 transcripts that differed more than twofold in this study
would be likely to result in many fortuitous ®ndings. Recently,
statistical methods that separate disease-related and nondisease-related variation have been described based on a material with many individual samples [14]. (iii) Identi®cation of gene
expression patterns. This has been used for diagnostic classi®cation of oncological materials [15,16]. Such applications could
be very useful in allergy research, but also require many individual samples. To be able to do this, further improvement of
protocols or sensitivity of the DNA microarrays are needed.
In this study the analysis was restricted to 32 genes considered
relevant to mucosal responses [1±8,20±26]. It should be noted
that this restriction involved exclusion of many genes of known
relevance. However, the chosen genes allowed comparison with
previous studies as well as with proteins in nasal ¯uids. This may
be of particular interest for studies of allergic rhinitis. The
Fig. 3. RT-PCR analysis of IgA isoforms in
pooled nasal biopsies from the patients with
allergic rhinitis. The primers were designed to
amplify both Iga1 and IgA2 transcripts (380bp).
The restriction enzyme Eco RI speci®cally
digests IgA2 PCR product and the restriction
enzyme Hinf I speci®cally digests IgA1 PCR
product. The analysis shows that IgA1 is the
main expressed isoform. Abbreviations:
Mmolecular marker, NDnon-digested PCR
product, Eco RIEco RI digested PCR product,
Hinf I Hinf I digested PCR product. The ®gures
to the left of the DNA ladder indicate the 516 and
220 fragments of the molecular marker.
relevance of a transcript detected in pooled biopsies might be
tried statistically after analysing the corresponding protein in
a larger number of nasal ¯uid samples. In this report, group
differences and correlations were analysed. In terms of biological effects it may also be important to make detailed studies
of proteins, e.g. the allergen-speci®city of immunoglobulins.
There were great quantitative variations in gene expression;
the expression level of IgA in the patients was approximately
1000 times higher than that of IgE, which was not present
according to the absolute call criterion. These proportions
were similar to the concentrations of the corresponding proteins
in nasal ¯uids. This could imply that mucosal gene expression
and proteins in nasal ¯uids are closely associated. However,
there were also differences between mRNA and protein expression; while albumin was absent in the mucosa, high concentrations were found in the nasal ¯uids from the patients. This
can be explained by extravasation of albumin from the capillary
bed to the nasal ¯uids [35]. Similarly, while transcripts for
eosinophil and neutrophil granulae proteins were absent in the
mucosa, they were present in high protein concentrations in
nasal ¯uids. This could depend on granulae proteins being
synthesized during differentiation of granulocytes in the bone
marrow, rather than in the mucosa [36]. Moreover, granulocytes are more common in nasal ¯uids than in the mucosa, in
which mononuclear cells predominate [9]. These ®ndings highlight that allergic in¯ammation results from interactions between different compartments with different roles. The data in
this study indicate that the nasal mucosa is an important source
of immunoglobulins. This has been previously shown by immunohistochemical studies [5±8]. However, with the exception
of IgE [5,7] this is the ®rst report demonstrating local mRNA
for immunoglobulins and their receptors.
Of all analysed transcripts IgA was the most highly expressed.
The role of IgA in allergic in¯ammation is not clearly de®ned.
Early studies indicated that atopy was associated with defective
allergen elimination due to IgA de®ciency [37]. This was not
supported by later studies of IgA in serum, sputum and nasal
secretions of allergic patients [38±40]. Moreover, IgA may
induce eosinophil degranulation. This has been shown by
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
DNA microarrays
experimental studies and supported by correlations between
IgA and ECP in nasal ¯uids from patients with allergic rhinitis,
following allergen challenge [4,41]. Understanding of the
possible role of IgA in allergic in¯ammation is complicated by
the existence of two subclasses, IgA1 and IgA2. Immunohistochemical studies indicate that IgA1 predominates in the
nasal mucosa [8]. This was con®rmed in this study by RT-PCR.
Recently this was also shown on the protein level, in nasal ¯uids
from healthy subjects [42]. This is the ®rst study to demonstrate
that IgA1 also predominates in nasal ¯uids from patients with
allergic rhinitis. It is not known if IgA1 and IgA2 have functional differences. In this study IgA1, but not IgA2, was signi®cantly correlated with ECP and EDN. This could indicate a
functional difference between the two subclasses in relation to
eosinophils. However, this possibility is not supported by
experimental data [43]. Moreover, the allergen speci®city of
the IgA is likely to be more important than the subclass. Bet
v 1-speci®c IgA was signi®cantly higher in nasal ¯uids from the
patients than the controls, and correlated with both ECP and
EDN. Given the abundance of IgA, the role of this antibody in
activation of eosinophils and other granulocytes warrants
further elucidation. It is also of note that this complexity highlights the need to combine molecular and protein studies to gain
functional understanding of data derived from DNA microarrays.
The low expression of IgE mRNA in the nasal mucosa relative to other immunoglobulins probably re¯ects quantitative
differences in immunoglobulin synthesis. Nasal ¯uid total IgE
concentrations were low, and allergen-speci®c IgE not detectable. In addition to local synthesis, IgE may also be derived
from serum or lymph nodes, and the relative contributions from
these compartments remain to be de®ned [6]. Similarly, cytokines may be locally produced [1±3,7,21±24], or enter the nasal
mucosa and ¯uids as proteins stored in granulocytes [44].
Expression of receptors for cytokines and growth factors in the
mucosa was higher than their ligands. Similar proportions have
been described previously, both in nasal mucosa and ¯uid [3,20].
The expression of cytokine receptors was similar in patients and
controls. Previous studies of cytokine receptor expression have
shown variable results [25,45,46]. A possible explanation could
be that cytokine receptors are found on a wide variety of cells.
The effects of the receptor may therefore depend more on its
cellular distribution than its total quantity [2].
In summary, DNA microarray analysis may be used to
analyse gene expression in the nasal mucosa. Quantitatively
the transcriptional responses varied greatly, but were dominated by immunoglobulins and their receptors, particularly IgA.
Complementary studies of nasal ¯uid proteins indicated that
allergen-speci®c IgA might have a role in eosinophil degranulation. In combination with other methods, DNA microarray
studies may yield new understanding of the pathogenetic programmes underlying allergic in¯ammation.
Acknowledgements
We thank Ingemo Harrysson RN for expert help with obtaining
nasal biopsies, Helena Gunnlaugsdottir, Ann Reuterborg,
Bodil Persson for skilful laboratory work and Anders
Gummesson for help with the computer analysis. This study
was supported by grants from the Lundberg Foundation, the
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308
307
Swedish Medical Research Council, the Swedish Heart and
Lung Foundation, the Swedish Society against Asthma and
Allergy and the Tegger Foundation.
References
1 Christodoulopoulos P, Cameron L, Durham S, Hamid Q.
Molecular pathology of allergic disease. II. Upper airway disease.
J Allergy Clin Immunol 2000; 105:211±23.
2 Benson M, Adner M, Cardell LO. Cytokines and their receptors in
allergic rhinitis: relations to the Th2 hypothesis in allergy. Clin Exp
Allergy 2001; 31:361±8.
3 Polosa R, Prosperini G, Tomaselli V et al. Expression of c-erbB
receptors and ligands in human nasal epithelium. J Allergy Clin
Immunol 2000; 106:1124±31.
4 Motegi Y, Kita H, Kato M, Morikawa A. Role of secretory IgA,
secretory component, and eosinophils in mucosal in¯ammation. Int
Arch Allergy Immunol 2000; 122 (Suppl. 1):25±7.
5 Durham SR, Gould HJ, Thienes CP et al. Expression of epsilon
germ-line gene transcripts and mRNA for the epsilon heavy chain of
IgE in nasal B cells and the effects of topical corticosteroid. Eur
J Immunol 1997; 27:2899±906.
6 KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local
production and detection of (speci®c) IgE in nasal B-cells and
plasma cells of allergic rhinitis patients. Eur Respir J 2000;
15:491±7.
7 Cameron L, Hamid Q, Wright E et al. Local synthesis of epsilon
germline gene transcripts, IL-4, and IL-13 in allergic nasal mucosa
after ex vivo allergen exposure. J Allergy Clin Immunol 2000;
106:46±52.
8 Brandtzaeg P. The immune system of the nose and nasopharynx. In:
Mygind N, Pipkorn U, eds. Allergic and Vasomotor Rhinitis:
Pathophysiological Aspects. Copenhagen: Munksgaard,
1987:91±120.
9 Lim MC, Taylor RM, Naclerio RM. The histology of allergic
rhinitis and its comparison to cellular changes in nasal lavage. Am
J Respir Crit Care Med 1995; 151:136±44.
10 Harrington C, Rosenow C, Retiej J. Monitoring gene expression
using DNA microarrays. Curr Opin Microbiol 2000; 3:285±91.
11 Teague TK, Hildeman D, Kedl RM et al. Activation changes the
spectrum but not the diversity of genes expressed by T cells. Proc
Natl Acad Sci USA 1999; 26:12691±6.
12 Heller RA, Schena M, Chai A et al. Discovery and analysis of
in¯ammatory disease-related genes using cDNA microarrays. Proc
Natl Acad Sci USA 1997; 18:2150±5.
13 Alon U, Barkai N, Notterman DA et al. Broad patterns of gene
expression revealed by clustering analysis of tumor and normal
colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci
USA 1999; 96:6745±50.
14 Thomas JG, Olson JM, Tapscott SJ, Zhao LP. An ef®cient and
robust statistical modeling approach to discover differentially
expressed genes using genomic expression pro®les. Genome Res
2001; 11:1227±36.
15 Golub TR, Slonim DK, Tamayo P et al. Molecular classi®cation of
cancer: class discovery and class prediction by gene expression
monitoring. Science 1999; 286:531±7.
16 Khan J, Wei JS, Ringner M et al. Classi®cation and diagnostic
prediction of cancers using gene expression pro®ling and arti®cial
neural networks. Nat Med 2001; 7:673±9.
17 Mahadevappa M, Warrington JA. A high-density probe array
sample preparation method using 10- to 100-fold fewer cells. Nat
Biotechnol 1999; 17:1134±6.
18 Carlsson B, Jernas M, Lindell K, Carlsson LM. Total RNA and
array-based expression monitoring. Nat Biotechnol 2000;
18:579.
308 M. Benson et al.
19 Pullerits T, Linden A, Praks L, Cardell LO, LoÈtvall J. Upregulation
of nasal mucosal eotaxin in patients with allergic rhinitis. Clin Exp
Allergy 2000; 30:1469±75.
20 Benson M, Strannegard I-L, Strannegard O, Wennergren G.
Topical steroid treatment of allergic rhinitis decreases nasal
¯uid TH2 cytokines, eosinophils, eosinophil cationic protein,
and IgE but has no signi®cant effect on IFN-gamma, IL-1beta,
TNF-alpha, or neutrophils. J Allergy Clin Immunol 2000;
106:307±12.
21 Durham SR, Ying S, Varney VA et al. Cytokine messenger RNA
expression for IL-3, IL-4, IL-5, and granulocyte/macrophagecolony-stimulating factor in the nasal mucosa after local allergen
provocation: relationship to tissue eosinophilia. J Immunol 1992;
148:2390±4.
22 Bradding P, Mediwake R, Feather IH et al. TNF alpha is localized
to nasal mucosal mast cells and is released in acute allergic rhinitis.
Clin Exp Allergy 1995; 25:406±1.
23 Varga EM, Jacobson MR, Till SJ et al. Cellular in®ltration and
cytokine mRNA expression in perennial allergic rhinitis. Allergy
1999; 54:338±45.
24 Nouri-Aria KT, O'Brien F, Noble W et al. Cytokine expression
during allergen-induced late nasal responses. IL-4 and IL-5 mRNA
is expressed early (at 6 h) predominantly by eosinophils. Clin Exp
Allergy 2000; 30:1709±16.
25 Wright ED, Christodoulopoulos P, Small P, Frenkiel S, Hamid Q.
Th-2 type cytokine receptors in allergic rhinitis and in response to
topical steroids. Laryngoscope 1999; 109:551±6.
26 Varney VA, Jacobson MR, Sudderick RM et al. Immunohistology
of the nasal mucosa following allergen-induced rhinitis.
Identi®cation of activated T lymphocytes, eosinophils, and
neutrophils. Am Rev Respir Dis 1992; 146:170±6.
27 Ahl T, Reinholdt J. Subclass distribution of salivary secretory
immunoglobulin A antibodies to oral streptococci. Infect Immun
1991; 59:3619±25.
28 Reimer CB, Philips DJ, Aloisio CH, Black CM, Wells TW,
Speci®city and association constants of 33 monoclonal antibodies to
human IgA epitopes. Immunol Lett 1989; 21:209±15.
29 Baugh LR, Hill AA, Brown EL, Hunter CP. Quantitative analysis of
mRNA ampli®cation by in vitro transcription. Nucl Acid Res 2001;
29:E29.
30 Draghici S, Kuklin A, Hoff B, Shams S. Experimental designs,
analysis of variance and slide quality assessment in gene expression
arrays. Curr Opinion Drug Disc Develop 2001; 4:332±7.
31 Der SD, Zhou A, Williams BR, Silverman RH. Identi®cation of
genes differentially regulated by interferon alpha, beta, or gamma
using oligonucleotide arrays. Proc Natl Acad Sci USA 1998;
95:15623±8.
32 Wang Y, Rea T, Bian J, Gray S, Sun Y. Identi®cation of the genes
responsive to etoposide-induced apoptosis: application of DNA
chip technology. FEBS Lett 1999; 445:269±73.
33 Ishii M, Hashimoto S, Tsutsumi S et al. Direct comparison of
GeneChip and SAGE on the quantitative accuracy in transcript
pro®ling analysis. Genomics 2000; 68:136±43.
34 Warrington JA, Nair A, Mahadevappa M, Tsyganskaya M.
Comparison of human adult and fetal expression and identi®cation
of 535 housekeeping/maintenance genes. Physiol Genomics 2000;
2:143±7.
35 Wilson SJ, Lau L, Howarth PH. In¯ammatory mediators in
naturally occurring rhinitis. Clin Exp Allergy 1998; 28:220±7.
36 Gleich GJ. Mechanisms of eosinophil-associated in¯ammation.
J Allergy Clin Immunol 2000; 105:51±63.
37 Soothill JF. Immunode®ciency and allergy. Clin Allergy 1973;
1:511±9.
38 Turk A, Lichtenstein LM, Norman PS. Nasal secretory antibody to
inhalant allergens in allergic and non-allergic patients. Immunology
1970; 19:85±95.
39 Salvaggio JE, Lopez M, Arquembourg PC, Waldman RH, Sly M.
Salivary, nasal wash and sputum IgA concentrations in atopic and
non-atopic individuals. J Allergy 1973; 51:335±43.
40 Platt-Mills TAE, von Maur RK, Ishizaka K, Norman PS,
Lichtenstein LM. IgA and IgG anti-ragweed antibodies in nasal
secretion. J Clin Invest 1976; 57:1041±9.
41 Terada N, Terada Y, Shirotori K et al. Immunoglobulin as an
eosinophil degranulation factor: change in immunoglobulin level in
nasal lavage ¯uid after antigen challenge. Acta Otolaryngol 1996;
116:863±7.
42 Kirkeby L, Rasmussen TT, Reinholdt J, Kilian M.
Immunoglobulins in nasal secretions of healthy humans: structural
integrity of secretory immunoglobulin A1 (IgA1) and occurrence of
neutralizing antibodies to IgA1 proteases of nasal bacteria. Clin
Diagn Lab Immunol 2000; 7:31±9.
43 Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ.
IgA-induced eosinophil degranulation. J Immunol 1989;
142:2393±400.
44 Moqbel R, Lacy P. Effector functions of eosinophil cytokines. Clin
Exp Allergy 2000; 30:1667±71.
45 Cameron L, Christodoulopoulos P, Lavigne F et al. Evidence for
local eosinophil differentiation within allergic nasal mucosa:
inhibition with soluble IL-5 receptor. J Immunol 2000; 164:1538±45.
46 Benson M, Strannegard IL, Wennergren G, Strannegard O.
Increase of the soluble IL-4 receptor (IL-4sR) and positive
correlation between IL-4sR and IgE in nasal ¯uids from
school children with allergic rhinitis. Allergy Asthma Proc 2000;
21: 89±95.
# 2002 Blackwell Science Ltd, Clinical and Experimental Allergy, 32:301308